Become A Clinical Trial Volunteer - Touch Another Life
Uh-oh! This study is no longer available.

We're sorry, but the study or condition you’re looking for is no longer available. You can search all currently enrolling studies or contact us if you have any questions.

Type 2 Diabetes (T2D) – Evaluating Doses of Ozempic®

Medical Condition

Diabetes (Type 2 Diabetes)

Facility/Clinic

PMG Research of Salisbury

Age

18 or older

Gender

Male/Female

Description

A research study is evaluating the effects of various doses of Ozempic® on glycemic control and body weight in adults with type 2 diabetes.

This research study may be an option if you: 
Have been diagnosed with T2D
Have an HbA1c between 8 – 10%
Are on a stable daily dose of metformin alone or in combination with sulfonylureas 
Do not have uncontrolled and potentially unstable diabetic retinopathy or maculopathy

Other criteria apply.  Please make sure to discuss with a member of our research staff to ensure this research study is a good fit for you.

Qualified participants will receive all study-related care and Ozempic® (semaglutide) at no cost.

Enrollment

Open

Patient Commitment Duration

Approximately 10 months

Patient Compensation

Financial compensation may be provided for time and travel expenses.  

Number of visits in study

Approximately 9 clinic visits and 2 phone calls

Apply for this Study Now